This work was supported by grants from the National Natural Science Foundation of China (No 81273497; 81573413), the Program for Changjiang Scholars and Innovative Research Team in University (No IRT1193), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Evidence suggests that neuroinflammation is involved in depression and that the cysteinyl leukotriene receptor 1 (CysLT1R) plays a potential pathophysiological role in several types of CNS disorders. Our previous s...
Aim: Cysteinyl leukotriene receptor 1 (CysLT1 receptor) is located in epithelial cells, and translocates from the plasma membrane to the nucleus in a ligand-dependent manner. Here, we investigated whether CysLT1 re...
Objective Our previous studies showed that the neuroprotective effect of pranlukast,a cysteinyl leukotriene receptor-1(CysLT1)antagonist,on global cerebral ischemia in rats.This study was performed to evaluate dose-an...
Project supported by the National Natural Science Foundation of China(№ 30672449)
Aim: To determine whether the cysteinyl leukotriene receptor 1 (CysLT1 receptor) modulates brain cryoinjury and whether the CysLT1 receptor antagonist pranlukast exerts a time-dependent protective effect on cryoinj...
Project supported by the National Natural Science Foundation of China(№30371637).
Aim: To determine whether cysteinyl leukotriene receptor 1 (CysLT1 receptor) is involved in N-methyl-D-aspartate (NMDA)-induced excitotoxic injury in the mouse brain. Methods: Brain injury was induced by NMDA mi...
Project supported by the National Natural Science Foundation of China(№30271498).
Aim: To determine whether pranlukast, a cysteinyl leukotriene receptor-1 antagonist, exerts an anti-inflammatory effect on focal cerebral ischemia in mice. Methods: Focal cerebral ischemia in mice was induced by per...